Chandrakumar Harshith, Khatun Nazima, Gupta Tanuj, Graham-Hill Suzette, Zhyvotovska Angelina, McFarlane Samy I
Internal Medicine, State University of New York (SUNY) Downstate Health Sciences University Hospital, Brooklyn, USA.
Cardiology, Kings County Hospital Center, Brooklyn, USA.
Cureus. 2023 Feb 7;15(2):e34723. doi: 10.7759/cureus.34723. eCollection 2023 Feb.
Obesity is a major public health problem that is associated with serious comorbidities and premature mortality. Cardiovascular disease (CVD) is the major cause of morbidity and mortality associated with obesity. Lifestyle modifications, pharmacological therapy, and weight reduction surgery are the major interventions to date available for obesity management. Bariatric surgery has been increasingly utilized as a therapeutic option for obesity. In this meta-analysis, we aim to assess the effects of bariatric surgery on CVD outcomes and cardiovascular mortality. This study was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) checklist. PubMed, Embase, Cochrane Library, Google Scholar, and Web of Science were searched until 03/01/2022. Our search included three types of bariatric surgery: Roux-en-Y gastric bypass (RYGB), sleeve gastrectomy, and gastric banding (GB). All were searched in conjunction with "coronary artery disease," "ischemic heart disease," "myocardial infarction," "cerebrovascular accident," "stroke," "atrial fibrillation," "heart failure," "arrhythmias," and "mortality." We included 49 studies meeting the study criteria. Bariatric surgery showed a beneficial effect on coronary artery disease (CAD) (hazard ratio (HR) of 0.68 {95% confidence interval (CI): 0.52-0.91}, p = 0.008), myocardial infarction (MI) (HR of 0.53 {95% CI: 0.44-0.64}, p < 0.01) heart failure (HF) (HR of 0.45 {95% CI: 0.37-0.55}, p < 0.01), cerebrovascular accident (CVA) (HR of 0.68 {95% CI: 0.59-0.78}, p < 0.01), and cardiovascular mortality (HR of 0.48 {95% CI: 0.40-0.57}, p < 0.01). The effect on atrial fibrillation (AF) did not reach statistical significance: HR of 0.81 (95% CI: 0.65-1.01), p = 0.07. Our study, that is, an updated meta-analysis, including the three types of procedure, confirms beneficial effects on the major CVD outcomes, including coronary artery disease, myocardial infarction, cerebrovascular accident, and heart failure, and on CVD mortality. This study provides updated insights into the long-term CV effects of bariatric surgery, an increasingly common intervention for obesity.
肥胖是一个主要的公共卫生问题,与严重的合并症和过早死亡相关。心血管疾病(CVD)是与肥胖相关的发病和死亡的主要原因。生活方式改变、药物治疗和减重手术是迄今为止可用于肥胖管理的主要干预措施。减重手术已越来越多地被用作肥胖的治疗选择。在这项荟萃分析中,我们旨在评估减重手术对心血管疾病结局和心血管死亡率的影响。本研究是按照系统评价和荟萃分析的首选报告项目(PRISMA)清单进行的。检索了PubMed、Embase、Cochrane图书馆、谷歌学术和科学网,直至2022年1月3日。我们的检索包括三种减重手术:Roux-en-Y胃旁路术(RYGB)、袖状胃切除术和胃束带术(GB)。所有检索均结合“冠状动脉疾病”“缺血性心脏病”“心肌梗死”“脑血管意外”“中风”“心房颤动”“心力衰竭”“心律失常”和“死亡率”进行。我们纳入了49项符合研究标准的研究。减重手术对冠状动脉疾病(CAD)显示出有益效果(风险比(HR)为0.68 {95%置信区间(CI):0.52 - 0.91},p = 0.008)、心肌梗死(MI)(HR为0.53 {95% CI:0.44 - 0.64},p < 0.01)、心力衰竭(HF)(HR为0.45 {95% CI:0.37 - 0.55},p < 0.01)、脑血管意外(CVA)(HR为0.68 {95% CI:0.59 - 0.78},p < 0.01)和心血管死亡率(HR为0.48 {95% CI:0.40 - 0.57},p < 0.01)。对心房颤动(AF)的影响未达到统计学意义:HR为0.81(95% CI:0.65 - 1.01),p = 0.07。我们的研究,即一项更新的荟萃分析,包括这三种手术方式,证实了对主要心血管疾病结局,包括冠状动脉疾病、心肌梗死、脑血管意外和心力衰竭,以及对心血管死亡率有有益影响。这项研究为减重手术这一越来越常见的肥胖干预措施的长期心血管影响提供了更新的见解。